Formulations of low dose diclofenac and beta-cyclodextrin
US8946292B2 · kind B2 · utility
3Cited by
38References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 12, 2011 |
| Grant date | Feb 3, 2015 |
| Priority date | — |
| Expiry date | May 12, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC08B37/0015
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to a pharmaceutical composition containing a unit dose of a diclofenac compound effective to induce analgesia; and a beta-cyclodextrin compound; wherein the dose of the diclofenac compound is less than 75 mg, e.g., from about 18.75 mg to about 37.5 mg. The present invention is also directed to methods of treating a subject in need of analgesia with the pharmaceutical compositions of the invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.